Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
Masterclass on Non-muscle-invasive bladder cancer
Home
/
Systemic versus intravesical drug from high-risk NMIBC naive from BCG
Back
Systemic versus intravesical drug from high-risk NMIBC naive from BCG
2023-11-05
Prof. A.M. Kamat (US) gives his presentation at EMUC23’s plenary session “Innovative concepts and new modalities of treatment in urothelial carcinomas”.
Share:
Previous
Next